Precision surgery in lung metastasectomy.
Biomarkers, Tumor
/ analysis
Chemotherapy, Adjuvant
Clinical Decision-Making
Colorectal Neoplasms
/ diagnosis
Disease-Free Survival
Humans
Lung
/ diagnostic imaging
Lung Neoplasms
/ diagnosis
Lymph Node Excision
Lymph Nodes
/ pathology
Lymphatic Metastasis
/ diagnosis
Margins of Excision
Patient Selection
Pneumonectomy
/ methods
Prognosis
Thoracic Surgery, Video-Assisted
/ methods
Tomography, X-Ray Computed
FDG-PET
colorectal cancer
pulmonary anatomical resection
pulmonary metastasectomy
pulmonary metastases
thoracoscopy
Journal
Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
21
12
2019
medline:
9
3
2021
entrez:
21
12
2019
Statut:
ppublish
Résumé
The value of pulmonary metastasis (PM) resection in the context of controlled primary tumor sites was shown to improve survival of patients if complete resection could be achieved. The surgeon's approach can be modulated by various parameters pertaining to safety margins including local growth properties, size, spread and location of PMs. Lymph node dissection and assessment is recommended although its impact on survival remains unclear. Thoracoscopic surgery combined to thin slice chest CT scans has shown results comparable to thoracotomy in patients with few PMs. The management of PMs should therefore be discussed on an individual, interdisciplinary basis to offer the best possible oncological and surgical results as well as to maximize long term patient survival rates.
Identifiants
pubmed: 31858825
doi: 10.2217/fon-2018-0713
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM